Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
NCT Number: NCT00090389
The purpose of this study is to evaluate the safety and effectiveness of acupuncture in treating women's health conditions.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 1
Boston, Massachusetts, 02115, United States
This trial comprises three studies. In the first two studies, women will be randomly assigned to receive either real or sham acupuncture therapy. Study 1 will include women with various forms of cancer. White blood cell counts will be used to assess the effects of acupuncture on participants' immune responses. Study 2 will include women with unspecified pelvic pain and endometriosis; a self-report pain scale will be used to assess the effects of acupuncture on participants' symptoms. Study 3 will evaluate the validity and reliability of diagnoses made by Chinese medicine practitioners. In this study, a group of Chinese medicine practitioners will diagnose the same group of patients; consistency of the diagnoses will be evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Study 1:
Inclusion criteria
for Study 2:
Currently closed to recruitment
Exclusion criteria
for Studies 1 and 2:
National Center for Complementary and Integrative Health (NCCIH)
Nih
New England School of Acupuncture (NESA) Acupuncture Research Collaborative
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01654458
Adnexal Diseases, Endocrine Gland Neoplasms
New York, United States
View Trial DetailsNCT04351139
Adnexal Diseases, Breast Neoplasm Female
Bron, France
View Trial DetailsNCT02454036
Adnexal Diseases, Endocrine Gland Neoplasms
Lexington, Kentucky, United States
View Trial DetailsNCT02444195
Adnexal Diseases, Endocrine Gland Neoplasms
Ann Arbor, Michigan, United States
View Trial Details